Interested in Medipost Cartistem? On this page, we have collected links for you, where you will receive the most necessary information about Medipost Cartistem.


CARTISTEM® - MEDIPOST

    http://www.medi-post.com/cartistem/
    CARTISTEM® – allogeneic umbilical cord blood-derived mesenchymal stem cells, is used for the treatment of knee cartilage defects in patients with Osteoarthritis (with ICRS grade* IV cartilage defect) caused by degeneration or repetitive trauma. *ICRS grade …

The Future of Biotechnology - MEDIPOST

    http://www.medi-post.com/
    CARTISTEM® Treatment of knee cartilage defects including for patients with Knee Osteoarthritis CARTISTEM ® – allogeneic umbilical cord blood-derived mesenchymal stem cells, is used for the treatment of knee cartilage defects in patients with …

COMPANY - MEDIPOST

    http://www.medi-post.com/intro/
    MEDIPOST successfully commercialized allogeneic cord blood-derived mesenchymal stem cell product named CARTISTEM ®, as the world’s first regulatory approved allogeneic stem cell product approved by the Ministry of Food and Drug Safety …

NEUROSTEM® - MEDIPOST

    http://www.medi-post.com/neurostem/
    MEDIPOST Initiates Phase-2 Clinical Trial of CARTISTEM in Japan 2020.09.21 MEDIPOST’s CEO Dr Yang Yoonsun Named on the Forbes 2020 List of Asia’s Power Businesswomen 2020.09.16 MEDIPOST Completes Phase 2a Clinical Trial of NEUROSTEM for Alzheimer’s Disease 2020.07.07

GMP Facility - MEDIPOST

    http://www.medi-post.com/gmp/
    CARTISTEM ®, allogeneic cord blood-derived mesenchymal stem cell product, is produced and commercially released from the MEDIPOST ’s state-of-the-art GMP manufacturing through Quality Management System (QMS) for high-standard pharmaceutical manufacturing facility in compliance with the GMP standards of the Ministry of Food and Drug Safety (MFDS) of Korea and the Pharmaceutical …

[INTERVIEW] Medipost to unlock potential in regenerative ...

    https://koreatimes.co.kr/www/tech/2019/12/694_279684.html
    Dec 04, 2019 · Medipost's Cartistem cartilage regeneration therapy / Courtesy of Medipost Buoyed by Cartistem's success, Medipost is now working on a new knee …

Mesenchymal stem cell therapy for cartilage repair - Medipost

    https://adisinsight.springer.com/drugs/800034605
    Mar 01, 2021 · Mesenchymal stem cell therapy for cartilage repair - Medipost Alternative Names: Cartistem; SMUP-IA-01 Latest Information Update: 01 Mar 2021. Price : $50 * Buy Profile. Adis is an information provider. We do not sell or distribute actual drugs. Final gross price and currency may vary according to local VAT and billing address. ...

Cartistem - Product Profile - BCIQ

    https://bciq.biocentury.com/products/cartistem
    Cartistem regulatory update...Medipost said the Korea Food and Drug Administration approved Cartistem to treat osteoarthritis.

Home - Medipost Pharmacy

    https://medipost.co.za/
    Medipost is a national pharmacy, delivering medication to more than 595 000 satisfied patients across South Africa. Medipost employs 1736 staff members, of which 469 are highly skilled pharmacists and pharmacist assistants with dedicated medical scheme responsibilities.

Contact Us - Medipost Pharmacy

    https://medipost.co.za/contact-us/
    Medipost Gezina Walk-in Pharmacy Trading Hours: Weekdays – 08h00 to 17h00 (Except Wednesdays – 09h00 to 17h00) Saturdays – 08h00 to 12h00.

We hope you have found all the information you need about Medipost Cartistem through the links above.


Previous -------- Next

Related Pages